These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6153637)

  • 1. Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; Lemmens PJ; van Boven CP
    Infect Immun; 1980 Jan; 27(1):204-10. PubMed ID: 6153637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclease-sensitive ribosomal vaccines.
    Gonggrijp R; Antonissen AC; van den Bosch JF; van Boven CP
    Antonie Van Leeuwenhoek; 1984; 50(5-6):763-74. PubMed ID: 6084981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase-sensitive and RNase-insensitive protective components isolated from Listeria monocytogenes.
    Antonissen AC; Lemmens PJ; Gonggrijp R; van den Bosch JF; van Boven CP
    Antonie Van Leeuwenhoek; 1985; 51(2):227-40. PubMed ID: 2412492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the presence of lipopolysaccharide in a ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Volleberg MP; Lemmens PJ; van Boven CP
    Infect Immun; 1981 Mar; 31(3):896-905. PubMed ID: 6785242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; van Boven CP
    Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
    Gonggrijp R; Mullers WJ; van Boven CP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between enhanced resistance and delayed hypersensitivity induced with subcellular preparations from Listeria monocytogenes and the adjuvant dimethyl-dioctadecyl-ammonium bromide.
    Antonissen AC; Lemmens PJ; van den Bosch JF; van Boven CP
    Antonie Van Leeuwenhoek; 1986; 52(1):75-84. PubMed ID: 2425734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
    Lieberman MM
    Infect Immun; 1978 Jul; 21(1):76-86. PubMed ID: 101464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens by ribosomal vaccines from Pasteurella multocida: dependence on homologous lipopolysaccharide.
    Phillips M; Rimler RB
    Am J Vet Res; 1984 Sep; 45(9):1785-9. PubMed ID: 6208828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium.
    Venneman MR; Bigley NJ
    J Bacteriol; 1969 Oct; 100(1):140-8. PubMed ID: 4898982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Johnson W
    Infect Immun; 1972 Jun; 5(6):947-52. PubMed ID: 4564407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotective activity of capsular polysaccharide in Klebsiella pneumoniae ribosomal preparations does not involve ribonucleic acid.
    Riottot MM; Fournier JM
    Infect Immun; 1981 Oct; 34(1):126-30. PubMed ID: 6170582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis.
    Youmans AS; Youmans GP
    J Bacteriol; 1966 Jun; 91(6):2146-54. PubMed ID: 4957610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and properties of an RNA fraction present in Brucella culture supernatants.
    Corbel MJ; Brewer RA
    J Hyg (Lond); 1980 Apr; 84(2):223-36. PubMed ID: 6153668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
    Tewari RP; Lynn M; Birnbaum AJ; Solotorovsky M
    Infect Immun; 1978 Jan; 19(1):58-65. PubMed ID: 304844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the mode of action of ribosomal vaccines from Klebsiella and Streptococcus pneumoniae and their ribonucleic and protein fractions using passive immunization.
    Robert D; Ivanoff B; Fontanges R; Normier G; Pinel AM; Dussourd D'Hinterland L
    Microbiol Immunol; 1982; 26(10):933-40. PubMed ID: 6186896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    Mates A; Zand P
    J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
    Lieberman MM; Frank WJ
    J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
    Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.